Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis (Crocodex)
Dexamethasone Intra-Erythrocyte Therapy in Patients With Chron's Disease or Ulcerative Colitis
Sponsor: Casa Sollievo della Sofferenza IRCCS
A PHASE2 clinical study on Ulcerative Colitis, this trial is completed. The trial is conducted by Casa Sollievo della Sofferenza IRCCS and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Jul 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Casa Sollievo della Sofferenza IRCCS
- Quince Therapeutics S.p.A.
For direct contact, visit the study record on ClinicalTrials.gov .